Pivotal role of endogenous TNF-alpha in the IL-2-driven activation and proliferation of the functionally immature NK free subset.
Highly purified peripheral blood-derived NK cells can be separated into three functionally defined subpopulations, namely, non-target binding free cells, binders, and killers. The free cell subset is the least mature and was examined for its response to IL-2-mediated activation and the role of endogenous secretion of TNF-alpha in its maturation and differentiation. The findings demonstrate that endogenous TNF-alpha secretion is prerequisite for the initiation of IL-2-mediated activation of free cells into killer cells. The addition of IL-2 to free cells upregulated the surface expression of IL-2R (TAC), TNF-R (p75), CD69, and ICAM-1 antigens and also stimulated cell proliferation. Furthermore, the addition of IL-2 to free cells resulted in the induction of cytotoxic activity and stimulation of free cells to become binder and killer cells. All of these IL-2-mediated manifestations are shown to be downregulated by the addition of anti-TNF-alpha antibody. However, IL-2-mediated TNF-alpha secretion was not affected by the addition of anti-TNF-alpha antibody. The specificity of the anti-TNF-alpha antibody-mediated inhibition was corroborated by the failure of the antibody to inhibit interferon-alpha-mediated activation of free cells into killer cells. Most of the events associated with the inhibitory activity of anti-TNF-alpha antibody were mimicked by the addition of IL-4 to IL-2-treated free cells. These findings suggest that the IL-2-mediated maturation and differentiation of the immature free cells to become cytotoxic and proliferate are the result of a sequence of events that are initiated by the secretion of endogenous TNF-alpha.
Jewett
A
A
Department of Microbiology and Immunology, UCLA School of Medicine 90024.
Bonavida
B
B
D000906:Antibodies; D000954:Antigens, Surface / Q000096:biosynthesis; D005434:Flow Cytometry; D006801:Humans; D007376:Interleukin-2 / Q000502:physiology*; D015847:Interleukin-4 / Q000502:physiology; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D008213:Lymphocyte Activation / Q000502:physiology; D016131:Lymphocyte Subsets / Q000502:physiology*; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000378:metabolism / Q000502:physiology*
D000906:Antibodies; D000954:Antigens, Surface; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D015847:Interleukin-4